Infant RSV immunity study
Part of Immune system & allergy, Infections, Lungs & breathing clinical trials.
Researchers want to study how infants naturally fight RSV infections. You and your baby may join if your baby is born in April, May, June, September, October, or November at BC Women's Hospital or a nearby hospital.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a birthing parent with a baby born in April, May, June, September, October, or November
- You delivered or plan to deliver at BC Women's Hospital or a nearby local hospital
- Your baby does not have a severe pregnancy complication or chronic condition that makes them automatically eligible for RSV shots in British Columbia
- Your baby was not born very early (before 35 weeks of pregnancy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows babies under 12 months old who are hospitalized with bronchiolitis to understand their treatment and outcomes. It includes tracking RSV testing and a new immunization called nirsevimab, which may help protect against severe illness.
This study tests a vaccine (called RSVpreF) for pregnant people living with HIV. The vaccine is meant to boost your own immunity so you can pass protection to your baby against RSV, a common and sometimes dangerous respiratory infection.
This study looks at how well RSV vaccines or antibody shots protect babies from severe respiratory infections. If your baby is under 1 year old, lives in Connecticut, and gets sick with a respiratory infection, they may be able to join.
This study looks at how well the RSV vaccine given to pregnant women (called ABRYSVO) protects babies from getting RSV after birth. It uses national health data from Scotland to track health outcomes.
This study tests two approved ways to prevent RSV, a common virus that can make babies very sick. Pregnant women may get a vaccine, and/or their babies may get an antibody shot after birth. The study compares these options to see which works best.
This study tests a new injection (SIBP-A16) designed to protect infants against RSV, a common virus that can cause serious lung infections in babies. The trial will see if the injection is safe and works in both premature and full-term infants during their first RSV season.
Hear when a new Respiratory Synctial Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.